GlassScriptPhysician profile
Christopher W Morris
NPI 1366451007
$1,347.99
in general payments reported to CMS, 2019-2025
25 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $693 · 2022: $400 · 2024: $130 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $259.01 | 2021-2025 | Veozah |
| Abbvie INC. | $162.36 | 2021-2025 | |
| Coloplast Corp | $148.83 | 2021-2022 | |
| Merz North America, INC. | $140.32 | 2022 | |
| Hollister Incorporated | $108.50 | 2021-2022 | |
| 180 Medical, INC. | $87.74 | 2021 | |
| Myovant Sciences INC. | $58.38 | 2022 | |
| Abbott Laboratories | $39.02 | 2024-2025 | Freestyle Libre 3 |
| Allergan, INC. | $38.96 | 2021-2022 | |
| Rochester Medical Corporation | $33.78 | 2021-2022 | |
| Procept Biorobotics Corporation | $27.09 | 2021 | |
| Becton, Dickinson and Company | $26.97 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Teleflex LLC | $23.36 | 2021 | |
| Smith+Nephew, INC. | $22.75 | 2022 | |
| Myriad Genetic Laboratories, INC. | $20.42 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.84 | 2021 | |
| Heron Therapeutics, INC. | $17.81 | 2025 | Aponvie |
| Axonics, INC. | $17.72 | 2021 | |
| Endo Pharmaceuticals INC. | $15.58 | 2021 | |
| Clarus Therapeutics INC. | $15.55 | 2021 | |
| Novo Nordisk INC | $15.01 | 2022 | |
| Convatec INC. | $14.47 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $12.38 | 2021 | |
| Galderma Laboratories, L.P. | $12.20 | 2022 | |
| Sagent Pharmaceuticals | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.